Company Page

Gamgee

Founders

Gamgee is an end-to-end platform for personalised mRNA cancer vaccines for dogs. The company sequences a dog's tumour and healthy DNA, identifies mutations unique to its cancer, and designs a bespoke vaccine that trains the immune system to attack it. Gamgee manages the entire process from vet intake and tissue collection through genomic analysis, vaccine production, treatment, and response monitoring. Currently running clinical trials in Australia and accepting cases globally, Gamgee is backed by Y Combinator (S26).

Company Founded in 2026